Literature DB >> 9773426

The intrahepatic cholangiopathies.

A Birnbaum1, F J Suchy.   

Abstract

The intrahepatic biliary epithelial cells or cholangiocytes are the primary focus of injury in many congenital and acquired liver diseases of childhood. Although cholangiocytes account for only 3 to 5% of the liver cell population, injury and progressive loss of intrahepatic bile ducts can result in considerable morbidity and mortality. Table 1 provides an overview of the various disorders that affect the intrahepatic biliary tree. The more common disorders are discussed in detail below. One of the most important cholangiopathies, biliary atresia, characterized by complete destruction of the extrahepatic biliary tree, with variable involvement of the intrahepatic bile ducts, is discussed elsewhere in this series of articles. There has been considerable progress in our understanding of the embryology and physiology of the intrahepatic biliary system. These topics are also selectively reviewed, with an emphasis on advances that aid in the understanding of the pathophysiology of the disorders which affect the biliary tract in children.

Entities:  

Mesh:

Year:  1998        PMID: 9773426     DOI: 10.1055/s-2007-1007162

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  4 in total

Review 1.  Experimental models to study cholangiocyte biology.

Authors:  Pamela S Tietz; Xian-Ming Chen; Ai-Yu Gong; Robert C Huebert; Anatoliy Masyuk; Tatyana Masyuk; Patrick L Splinter; Nicholas F LaRusso
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

2.  Duck hepatitis B virus replication in primary bile duct epithelial cells.

Authors:  J Y Lee; J G Culvenor; P Angus; R Smallwood; A Nicoll; S Locarnini
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Quantitative assessment of the rat intrahepatic biliary system by three-dimensional reconstruction.

Authors:  T V Masyuk; E L Ritman; N F LaRusso
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

4.  A mediastinal mass in end-stage liver disease.

Authors:  Harutomo Hasegawa; Gurjinder S Sandhu; Andrew V Thillainayagam; Nicola H Strickland; Simon D Taylor-Robinson
Journal:  J R Soc Med       Date:  2005-02       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.